Activation of mesangial cell MAPK in responseto homocysteine

Slides:



Advertisements
Similar presentations
Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Advertisements

Volume 56, Issue 5, Pages (November 1999)
Volume 114, Issue 5, Pages (May 1998)
Volume 68, Issue 4, Pages (October 2005)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Fig. 1 Effect of l-T4 and E2 on MAPK activation and serine-118 phosphorylation of ERα in MCF-7 cells. A, MCF-7 cells were treated.
Volume 60, Issue 2, Pages (August 2001)
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Volume 126, Issue 1, Pages (January 2004)
Volume 62, Issue 3, Pages (September 2002)
Volume 53, Issue 5, Pages (May 1998)
Volume 69, Issue 4, Pages (February 2006)
Richard T. Ethridge, Mark R. Hellmich, Raymond N. DuBois, B.Mark Evers 
S. Shastry, A.J. Ingram, J.W. Scholey, L.R. James  Kidney International 
Requirement of heat shock protein 90 in mesangial cell mitogenesis
Volume 59, Issue 1, Pages (January 2001)
Volume 67, Issue 3, Pages (March 2005)
Volume 118, Issue 4, Pages (April 2000)
Volume 58, Issue 3, Pages (September 2000)
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing.
Volume 63, Issue 2, Pages (February 2003)
Volume 126, Issue 1, Pages (January 2004)
by Xingwei Sui, Sanford B. Krantz, Min You, and Zhizhuang Zhao
Volume 60, Issue 5, Pages (November 2001)
Istvan Arany, Judit K. Megyesi, Jane E.B. Reusch, Robert L. Safirstein 
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 54, Issue 1, Pages (July 1998)
Volume 56, Issue 5, Pages (November 1999)
Volume 53, Issue 5, Pages (May 1998)
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes
Volume 68, Issue 3, Pages (September 2005)
Volume 67, Issue 6, Pages (June 2005)
Volume 56, Issue 4, Pages (October 1999)
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Volume 60, Issue 4, Pages (October 2001)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 59, Issue 1, Pages (January 2001)
Volume 118, Issue 6, Pages (June 2000)
PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3- kinase in mesangial cells  Jian Yao, Tetsuo Morioka, Takashi Oite  Kidney.
Volume 63, Issue 2, Pages (February 2003)
Volume 68, Issue 4, Pages (October 2005)
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor  L.D. Alexander, Y. Ding, S. Alagarsamy,
Volume 62, Issue 3, Pages (September 2002)
Volume 56, Issue 5, Pages (November 1999)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Hyaluronan increases glomerular cyclooxygenase-2 protein expression in a p38 MAP- kinase–dependent process  Marjorie E. Dunlop, Ph.D., Evelyne E. Muggli 
Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Volume 58, Pages S19-S25 (September 2000)
Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1  Sharon Silbiger, Jun Lei, Joel Neugarten  Kidney.
Xiangmei Chen, Wenhu Liu, Jianzhong Wang, Xiaodan Wang, Zhiheng Yu 
Volume 60, Issue 6, Pages (December 2001)
DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations  William A. Wilmer, Fernando G. Cosio 
Volume 61, Issue 5, Pages (May 2002)
Volume 61, Issue 6, Pages (June 2002)
Human Keratinocytes Respond to Osmotic Stress by p38 Map Kinase Regulated Induction of HSP70 and HSP27  M. Garmyn, A. Pupe  Journal of Investigative Dermatology 
Characterization of Keratinocyte Differentiation Induced by Ascorbic Acid: Protein Kinase C Involvement and Vitamin C Homeostasis1  Isabella Savini, Antonello.
Differential Regulation of Cyclooxygenase-2 Expression by Phytosphingosine Derivatives, NAPS and TAPS, and its Role in the NAPS or TAPS-Mediated Apoptosis 
STAT proteins mediate angiotensin II–induced production of TIMP-1 in human proximal tubular epithelial cells  Xiangmei Chen, Jianzhong Wang, Feng Zhou,
Volume 122, Issue 1, Pages (January 2002)
Volume 60, Issue 3, Pages (September 2001)
1α,25-Dihydroxyvitamin D3 Stimulates Activator Protein 1 DNA-Binding Activity by a Phosphatidylinositol 3-Kinase/Ras/MEK/Extracellular Signal Regulated.
Volume 70, Issue 5, Pages (September 2006)
Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells  S.-H. Wu, X.-H. Wu, C. Lu, L. Dong, G.-P.
Angiotensin III increases MCP-1 and activates NF-кB and AP-1 in cultured mesangial and mononuclear cells  Marta Ruiz-Ortega, Oscar Lorenzo, Jesus Egido 
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Signaling via Mitogen-Activated Protein Kinase Kinase (MEK1) Is Required for Golgi Fragmentation during Mitosis  Usha Acharya, Arrate Mallabiabarrena,
Volume 34, Issue 5, Pages (June 2009)
Deon G. Uffort, Elizabeth A. Grimm, Julie A. Ellerhorst 
Presentation transcript:

Activation of mesangial cell MAPK in responseto homocysteine Alistair J. Ingram, Joan C. Krepinsky, Leighton James, Richard C. Austin, Damu Tang, Anne Marie Salapatek, Kerri Thai, James W. Scholey  Kidney International  Volume 66, Issue 2, Pages 733-745 (August 2004) DOI: 10.1111/j.1523-1755.2004.00795.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Induction of Erk activity in mesangial cells by homocysteine (Hcy) is concentration- and time-dependent. The in vitro activity of Erk was measured in immunoprecipitates from mesangial cell lysates by detection of phosphorylation of an Elk-1 fusion protein by Western blotting. (A) Incubation of mesangial cells with Hcy for 1 hour at concentrations from 5 μmol/L to 5 mmol/L led to an increase in Erk activity that was maximal at 50 μmol/L (middle panel). No change in the amount of Erk protein was seen under any condition (top panel). Changes in activity are presented graphically with error bars (bottom panel) (N = 4). Erk activity at 50 μmol/L was significantly different from baseline and other concentrations (P < 0.01). (B) Incubation of mesangial cells with Hcy at 50 μmol/L for the times indicated led to an increase that was maximal at 20 minutes (middle panel). No change in the amount of Erk protein was seen under any condition (top panel). Changes in activity are presented graphically with error bars (bottom panel) (N = 4). Erk activity at 20 minutes only was significantly different from baseline and other time points (P < 0.05). MAPK is mitogen-activated protein kinase. Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Mediators of homocysteine Hcy-induced Erk activation in mesangial cells. The in vitro activity of Erk was measured in immunoprecipitates from mesangial cell lysates by detection of phosphorylation of an Elk-1 fusion protein by Western blotting. (A) Incubation of mesangial cells with 50 μmol/L Hcy for 20 minutes led to an increase in Erk activity that was unaffected by pre-incubation with n-acetylcysteine (1 mmol/L) nor catalase (Cat) (3000 U/mL) for 10 minutes prior to the addition of Hcy. The MEK inhibitor PD98059 effectively abrogated Erk activity, as anticipated (middle panel). No change in the amount of Erk protein was seen under any condition (top panel). Changes in activity are presented graphically with error bars (bottom panel) (N = 4). Erk activity in the presence of Hcy was significantly greater than baseline or Hcy with PD98059 (P < 0.01), but not different from Hcy with n-acetylcysteine or catalase. (B, located on the next page) The H2O2-sensitive fluorescent probe (CM-H2DCFDA) (Molecular Probes, Eugene, OR, USA) was used to assess the production of intracellular H2O2 and the ability of catalase and n-acetylcysteine to relieve oxidative stress in this system. Subconfluent quiescent mesangial cells were treated with 3000 U/mL catalase or 1 mmol/L n-acetylcysteine for 10 minutes prior to incubation with 50 μmol/L Hcy for 20 minutes, then fixed in formaldehyde, mounted in DAPI-containing mounting medium, and imaged using a fluorescent microscope. Panel A shows untreated cells; panel B shows mesangial cells exposed to 50 μmol/L Hcy for 20 minutes; panel C shows mesangial cells coincubated with Hcy and catalase (3000 U/mL); and panel D shows mesangial cells coincubated with Hcy and n-acetylcysteine (1 mmol/L). (C) Incubation of mesangial cells with 50 μmol/L Hcy for 20 minutes led to an increase in Erk activity that was abrogated by preincubation with BAPTA-AM (10 μmol/L) an intracellular calcium chelator, when added 10 minutes prior to Hcy. The 20-minute exposure to the calcium ionophore A23187 (1 μg/mL, Alexis) also activated Erk, although not to the same extent as Hcy (all middle panel). No change in the amount of Erk protein was seen under any condition (top panel). Changes in activity are presented graphically with error bars (bottom panel) (N = 4). Erk activity in response to Hcy or A23187 was signficantly greater than baseline or Hcy with BAPTA-AM (P < 0.03). Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Fig. 2B Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Homocysteine (Hcy) induces a rise in intracellular calcium in mesangial format. Mesangial cells grown on glass slips were loaded with Fura-2/AM and intracellular calcium measured after exposure to 50 μmol/L Hcy. A rapid peak in intracellular calcium after addition of 50 μmol/L Hcy is observed (N = 11). Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Nuclear translocation of phospho-ERK is induced by homocysteine (Hcy). Mesangial cells grown on glass slips were incubated with Hcy with or without inhibitors, permeabilized, and incubated with anti phospho-Erk for 30 minutes and subsequently with a secondary goat antirabbit green fluorescent-conjugated antibody and confocal laser scanning microscopy performed. (A) Background cytoplasmic and nuclear staining in normal mesangial cells. The addition of 50 μmol/L Hcy for 20 minutes (B) led to a prompt (20 minutes) increase in staining that was almost entirely nuclear in distribution. Preincubation with BAPTA-AM (10 μmol/L for 10 minutes) (C) abrogated the nuclear translocation of phospho-Erk observed with Hcy. Four separate experiments were performed and representative fields shown. Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Erk-dependent nuclear protein binding to activator protein-1 (AP-1) consensus sequences is induced by homocysteine (Hcy). Nuclear proteins were reacted with radiolabeled AP-1 consensus oligonucleotides for 20 minutes, electrophoresed, and autoradiographed. Lane 1 shows nuclear protein binding in normal mesangial cells. Addition of 50 μmol/L Hcy for 20 minutes led to an increase in nuclear protein binding (lane 2) that was unaffected by preincubation with n-acetylcysteine (1 mmol/L) or catalase (3000 U/mL) for 10 minutes prior to the addition of Hcy (lanes 3 and 4). The Erk inhibitor PD98059 (10 μmol/L for 10 minutes prior to Hcy) largely prevented the increase in nuclear protein binding (lane 5). Competition experiments were performed with excess unlabelled consensus oligonucleotides in 100× excess (lane 6). Four separate experiments were performed and a representative autoradiograph is shown. Densitometry revealed that nuclear protein binding to AP-1 consensus sequences in the presence of Hcy was significantly greater than baseline or Hcy with PD98059 (P < 0.05), but not different from Hcy with n-acetylcysteine or catalase. Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 6 Homocysteine (Hcy)-induced nuclear protein binding to activator protein-1 (AP-1) consensus sequences is calcium-dependent. Nuclear proteins were reacted with radiolabeled AP-1 consensus oligonucleotides for 20 minutes, electrophoresed, and autoradiographed. Lane 1 shows nuclear protein binding in normal mesangial cells. Addition of 50 μmol/L Hcy for 20 minutes led to an increase in nuclear protein binding (lane 2) that was prevented by preincubation with BAPTA-AM (10 μmol/L) for 10 minutes prior to the addition of Hcy (lanes 3 and 4).Competition experiments were performed with excess unlabeled consensus oligonucleotides in 100× excess (lane 5). Four separate experiments were performed and a representative autoradiograph is shown. Densitometry indicated that nuclear protein binding to AP-1 consensus sequences in the presence of Hcy was significantly greater than baseline or Hcy with BAPTA-AM (P < 0.02). Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 7 Mesangial cell DNA synthesis and proliferation is induced by homocysteine (Hcy). Mesangial cells were exposed to 50 μmol/L Hcy for 24 hours. DNA synthesis was assessed by [3H]-thymidine incorporation (A) and proliferation by Western blotting for proliferating cell nuclear antigen (PNCA) (B). In (A), Hcy increases mesangial cell [3H]-thymidine incorporation at 24 hours by a factor of 1.3, a statistically significant result (P < 0.05). Preincubation with either the MEK-1 inhibitor U0126 or BAPTA-AM prevented [3H]-thymidine incorporation in response to Hcy, and both inhibitors significantly prevented DNA synthesis when compared to either baseline or Hcy (P < 0.03). In (B), Hcy (lane 2) markedly increased PCNA expression, which was abrogated by preincubation with the Erk inhibitor PD98059 (10 μmol/L) (lane 3). Densitometric results are shown graphically below with error bars (N = 4). The increase in PCNA expression was significantly different in Hcy-treated cells when compared to baseline or Hcy with PD98059 (P < 0.05). Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 8 Mesangial cell Grp78 induction by homocysteine (Hcy). Mesangial cells were exposed to 50 μmol/L Hcy with or without 10 μmol/L U0126 for 24 hours and RNA extracted for Northern analysis. Each lane was loaded with 5 μg RNA and hybridized using a radiolabeled cDNA probe to Grp78. (A) A representative autoradiograph is shown (N = 3). (B) Densitometric results are shown graphically with error bars (N = 4). Statistical analysis revealed that only Hcy alone significantly increased Grp78 mRNA when compared to control (P < 0.05). Abbreviations are: Cys, cysteine; GAPDH, glyeraldehyde-3-phosphate dehydrogenase. Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 9 Mesangial cell endoplasmic reticulum stress protein induction by homocysteine (Hcy). Mesangial cells were exposed to 50 μmol/L Hcy for the times indicated and protein lysate recovered for immunoblotting with specific antisera. Each lane was loaded with 40 μg protein. A representative autoradiograph is shown (N = 3). Kidney International 2004 66, 733-745DOI: (10.1111/j.1523-1755.2004.00795.x) Copyright © 2004 International Society of Nephrology Terms and Conditions